Related Experiment Video
Updated: Sep 4, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Optimal single-arm two-stage designs with consideration of dependency on efficacy and safety
Huan Yin1, Weizhen Wang2,3, Zhongzhan Zhang3
1School of Mathematics and Physics, 47840North China Electric Power University, Beijing, People's Republic of China.
Abstract:
In phase II clinical trials on cancer, it is of great interest to establish the efficacy and safety of a new treatment simultaneously. Existing hypotheses may not achieve this goal effectively. We introduce two new sets of hypotheses that consider the association between the two factors, then construct the optimal two-stage designs for the hypotheses. The proposed designs strictly control the maximum type I error rate at the given nominal level , maintain the minimum power at least the given , and have the smallest expected total sample size under the null hypothesis. Furthermore, an algorithm is provided to compute these designs. R-codes are given in the Supplemental Material.
Insights
This study introduces new hypotheses and optimal two-stage designs for phase II cancer trials, effectively assessing treatment efficacy and safety simultaneously. The methods ensure strict error control and minimize sample size for better clinical trial design.
Area of Science:
- Clinical Trials
- Biostatistics
- Oncology
Background:
- Phase II clinical trials for cancer treatments require simultaneous evaluation of efficacy and safety.
- Existing statistical hypotheses may not adequately address this dual objective.
Purpose of the Study:
- To introduce novel hypotheses and optimal two-stage designs for phase II cancer trials.
- To effectively assess treatment efficacy and safety concurrently.
Main Methods:
- Development of two new sets of hypotheses considering the association between efficacy and safety factors.
- Construction of optimal two-stage designs based on these hypotheses.
- Provision of an algorithm for design computation and R-codes.
Main Results:
- The proposed designs strictly control the type I error rate at a nominal level.
- Minimum power is maintained at a specified level.
- The designs achieve the smallest expected total sample size under the null hypothesis.
Conclusions:
- The new statistical framework and designs offer an effective approach for simultaneous efficacy and safety evaluation in phase II cancer trials.
- These methods provide a statistically rigorous and efficient design for clinical research.
More Related Videos
13:54A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
Published on: August 18, 2023
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Related Concept Videos
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Comparing the Survival Analysis of Two or More Groups
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...